Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5001403 | 0.91 | CACNA2D1 (1.00) | CACNA2D1 | |
| SCHEMBL5001268 | 0.90 | CACNA2D1 (1.00) | CACNA2D1 | |
| SCHEMBL5004577 | 0.87 | CACNA2D1 (0.80) | CACNA2D1 | |
| SCHEMBL5001318 | 0.87 | CACNA2D1 (0.80) | CACNA2D1 | |
| SCHEMBL5004736 | 0.84 | CACNA2D1 (1.00) | CACNA2D1 | |
| SCHEMBL5004885 | 0.83 | CACNA2D1 (1.00) | CACNA2D1 | |
| SCHEMBL5008021 | 0.83 | CACNA2D1 (0.76) | CACNA2D1 | |
| SCHEMBL5005356 | 0.83 | CACNA2D1 (0.79) | CACNA2D1 | |
| SCHEMBL5008017 | 0.83 | CACNA2D1 (0.74) | CACNA2D1 | |
| SCHEMBL5008117 | 0.83 | CACNA2D1 (0.79) | CACNA2D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465730-B2 | Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds | MERCK & CO. INC. (US) | 2008-12-16 | — | — | US | disclosed |
| US-7465730-B2 | Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds | MERCK & CO. INC. (US) | 2008-12-16 | — | — | US | disclosed |
| WO-2004006836-A2 | TREATMENT OF NEUROPATHIC PAIN WITH 6H-PYRROLO[3,4-D]PYRIDAZINE COMPOUNDS | MERCK & CO., INC. (US) | 2004-01-22 | — | — | WO | disclosed |